Related stories
SpaceX is roughly 44% from its peak and about 16% below the IPO price itself. That's a strange outcome for a company that just executed a successful Starship test flight and controls roughly half of global orbital launch activity. The drop comes as five colliding pressures land at once.
Right now, only roughly 639M shares are available to trade. By early December, that number rises to 5.33B, according to SpaceX's prospectus.
The first major unlock hits on Aug. 4, the same day SpaceX reports its inaugural earnings, when 20% of early investor shares become tradable.
Additional tranches unlock at 70, 90, 105, and 135 days post-IPO, with more following after the second-quarter earnings report.
That schedule creates what investors call an overhang. Every potential buyer knows a larger wave of selling could be coming. The rational response is to wait.
SpaceX is turning away customers for its Falcon 9 rocket beyond 2028 and winding down production of some non-reusable components.
The company is betting its financial future on Starship, which it plans to use for orbital data centers.
The Falcon launch business generates revenue, but Starlink is the actual cash engine, according to the IPO filing.
The problem is timing. Winding down Falcon before Starship is fully operational creates real risk for the hundreds of satellite operators who depend on Falcon 9 rides.
Starship's current satellite deployment design, a slot-style door rather than an open nose cone, also forces some customers to rethink the physical shape of their spacecraft.
"The timing seems a bit aggressive. It's happening a couple years earlier than we expected."
Michael Leshock, KeyBanc Capital Markets
Morgan Stanley analyst Adam Jonas noted recently that at $100 per share, the market is assigning zero value to SpaceX's AI business. That's notable because AI accounts for more than 60% of his overall valuation model.
He maintains a Buy rating with a $300 price target and argues Starlink alone could be worth $136 per share.
For context on how far a high-profile IPO can fall, Meta Platforms dropped 53% from its IPO price in the four months after its May 2012 debut before recovering roughly 140% over the following year.
At least five firms, including Morgan Stanley and Marex Group Ltd., are rushing to offer SpaceX-linked structured notes. These are debt-like securities that blend fixed-income features with derivatives exposure.
Marex is offering a nine-month note paying at least 1.8% monthly interest with principal protection against declines up to 35%.
Morgan Stanley's version offers a fixed 40% payout at maturity in early 2028, as long as the stock is flat or down less than 50%. Beyond the 50% threshold, holders face full downside.
One advisor put the tradeoff plainly: these products cap upside on highly volatile companies but often expose investors to unlimited downside once the protection threshold is breached.
Six House members or their immediate families purchased between $83K and $245K in SpaceX shares within six days of the IPO.
Five of the six sit on committees overseeing defense, AI, satellite communications, or securities markets. SpaceX receives billions in federal contracts directed by the very lawmakers who own the stock.
The trades were legal. The House recently passed the Stop Insider Trading Act, which would ban new individual stock purchases but allow members to hold existing positions and sell with advance notice. The bill now moves to the Senate.
FAA proposals to streamline space launch approvals gave the stock a brief Tuesday boost, but shares resumed their slide by Wednesday. The regulatory tailwind is strong but it just isn't enough (on its own) to offset everything else in the queue.
